Elanco Animal Health, Inc. (ELAN)
24.41
+0.44
(+1.84%)
USD |
NYSE |
Aug 24, 16:00
24.41
0.00 (0.00%)
After-Hours: 20:00
Elanco Animal Health Total Assets (Quarterly) : 13.56B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.56B |
| March 31, 2026 | 13.22B |
| December 31, 2025 | 13.36B |
| September 30, 2025 | 13.55B |
| June 30, 2025 | 13.74B |
| March 31, 2025 | 12.94B |
| December 31, 2024 | 12.61B |
| September 30, 2024 | 13.28B |
| June 30, 2024 | 13.76B |
| March 31, 2024 | 14.02B |
| December 31, 2023 | 14.36B |
| September 30, 2023 | 14.34B |
| June 30, 2023 | 15.80B |
| March 31, 2023 | 15.77B |
| December 31, 2022 | 15.49B |
| September 30, 2022 | 14.95B |
| June 30, 2022 | 15.60B |
| Date | Value |
|---|---|
| March 31, 2022 | 16.25B |
| December 31, 2021 | 16.48B |
| September 30, 2021 | 16.56B |
| June 30, 2021 | 16.83B |
| March 31, 2021 | 16.99B |
| December 31, 2020 | 17.69B |
| September 30, 2020 | 17.24B |
| June 30, 2020 | 9.876B |
| March 31, 2020 | 9.727B |
| December 31, 2019 | 8.986B |
| September 30, 2019 | 8.824B |
| June 30, 2019 | 8.857B |
| March 31, 2019 | 8.747B |
| December 31, 2018 | 8.957B |
| September 30, 2018 | 9.212B |
| June 30, 2018 | 8.577B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Zoetis, Inc. | 15.08B |
| Eli Lilly & Co. | 142.28B |
| ANI Pharmaceuticals, Inc. | 1.494B |
| EyePoint, Inc. | 228.19M |
| Amylyx Pharmaceuticals, Inc. | 264.56M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.973B |
| Shareholders Equity (Quarterly) | 6.588B |
| Debt to Equity Ratio | 0.5947 |
| Current Ratio | 2.050 |
| Net Debt Paydown Yield | 0.78% |